Your browser doesn't support javascript.
loading
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer.
Anagnostou, Valsamo; Niknafs, Noushin; Marrone, Kristen; Bruhm, Daniel C; White, James R; Naidoo, Jarushka; Hummelink, Karlijn; Monkhorst, Kim; Lalezari, Ferry; Lanis, Mara; Rosner, Samuel; Reuss, Joshua E; Smith, Kellie N; Adleff, Vilmos; Rodgers, Kristen; Belcaid, Zineb; Rhymee, Lamia; Levy, Benjamin; Feliciano, Josephine; Hann, Christine L; Ettinger, David S; Georgiades, Christos; Verde, Franco; Illei, Peter; Li, Qing Kay; Baras, Alexander S; Gabrielson, Edward; Brock, Malcolm V; Karchin, Rachel; Pardoll, Drew M; Baylin, Stephen B; Brahmer, Julie R; Scharpf, Robert B; Forde, Patrick M; Velculescu, Victor E.
Afiliação
  • Anagnostou V; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. vanagno1@jhmi.edu.
  • Niknafs N; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA. vanagno1@jhmi.edu.
  • Marrone K; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Bruhm DC; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • White JR; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Naidoo J; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Hummelink K; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Monkhorst K; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lalezari F; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lanis M; Antoni van Leeuwenhoek Nederlands Kanker Instituut, Amsterdam, the Netherlands.
  • Rosner S; Antoni van Leeuwenhoek Nederlands Kanker Instituut, Amsterdam, the Netherlands.
  • Reuss JE; Antoni van Leeuwenhoek Nederlands Kanker Instituut, Amsterdam, the Netherlands.
  • Smith KN; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Adleff V; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Rodgers K; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Belcaid Z; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Rhymee L; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Levy B; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Feliciano J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Hann CL; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Ettinger DS; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Georgiades C; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Verde F; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Illei P; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Li QK; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Baras AS; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Gabrielson E; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Brock MV; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Karchin R; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Pardoll DM; Department of Radiology and Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Baylin SB; Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Brahmer JR; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Scharpf RB; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Forde PM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Velculescu VE; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Nat Cancer ; 1(1): 99-111, 2020 01.
Article em En | MEDLINE | ID: mdl-32984843
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido